In France, the landscape for Next-Generation Sequencing (NGS) is promising, marked by a robust infrastructure and widespread use of technology across healthcare and research. However, despite strong adherence to clinical guidelines, challenges loom regarding reimbursement complexities and a potential shortage in specialized healthcare personnel. While collaborations face limitations, the nation emphasizes stringent data security and integration.

For a comprehensive understanding and in-depth analysis of France’s molecular diagnostics scenario, the detailed report is available for download below.